| Register
| Log out
Submit An Article

spl

Latest Articles

  • Starpharma gains regulatory approval in Malaysia for nasal spray to build momentum in Asia

    Starpharma gains regulatory approval in Malaysia for nasal spray to build momentum in Asia

    Biopharmaceutical company Starpharma (ASX: SPL) has received regulatory approval for its antiviral nasal spray product, VIRALEZE, in Malaysia. This milestone achievement grants Starpharma and its commercial partners the opportunity to market and sell the innovative product in Malaysia, a country with a population exceeding 33 million.  VIRALEZE has garnered significant recognition in Asia following successful

    Read More
    Public
  • Why reinvent the wheel? Starpharma is using their tech to improve existing drugs

    Why reinvent the wheel? Starpharma is using their tech to improve existing drugs

    We live in the age of optimisation. Constantly asking questions like how can we be more efficient? How can we streamline processes? How can we enhance ourselves with the resources available?  The pharmaceutical scene is no different, seeking to optimise drugs in any way possible to produce better patient outcomes.  Biopharmaceutical company Starpharma (ASX: SPL)

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.